Brainstorm Cell Therapeutics Inc. (BCLI)

BCLI Statistics

Total Valuation

BCLI has a market cap or net worth of $12.72 million. The enterprise value is $13.39 million.

Market Cap	12.72M
Enterprise Value	13.39M

Important Dates

The last earnings date was Thursday, November 14, 2024, after market close.

Earnings Date	Nov 14, 2024
Ex-Dividend Date	n/a

Share Statistics

BCLI has 5.70 million shares outstanding. The number of shares has increased by 69.79% in one year.

Current Share Class	5.70M
Shares Outstanding	5.70M
Shares Change (YoY)	+69.79%
Shares Change (QoQ)	+11.84%
Owned by Insiders (%)	7.46%
Owned by Institutions (%)	4.78%
Float	4.61M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.05

Current Ratio	0.05
Quick Ratio	0.03
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-35.02

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-215.84%
Return on Capital (ROIC)	n/a
Revenue Per Employee	n/a
Profits Per Employee	-$490,621
Employee Count	29
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -24.76% in the last 52 weeks. The beta is 0.35, so BCLI's price volatility has been lower than the market average.

Beta (5Y)	0.35
52-Week Price Change	-24.76%
50-Day Moving Average	1.71
200-Day Moving Average	4.87
Relative Strength Index (RSI)	62.80
Average Volume (20 Days)	125,959

Short Selling Information

The latest short interest is 152,370, so 2.67% of the outstanding shares have been sold short.

Short Interest	152,370
Short Previous Month	148,229
Short % of Shares Out	2.67%
Short % of Float	3.31%
Short Ratio (days to cover)	1.25

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-13.31M
Pretax Income	-15.53M
Net Income	-14.23M
EBITDA	-13.06M
EBIT	-13.31M
Earnings Per Share (EPS)	-$3.20

Balance Sheet

The company has $168,000 in cash and $841,000 in debt, giving a net cash position of -$673,000 or -$0.12 per share.

Cash & Cash Equivalents	168,000
Total Debt	841,000
Net Cash	-673,000
Net Cash Per Share	-$0.12
Equity (Book Value)	-6.06M
Book Value Per Share	-1.14
Working Capital	-6.72M

Cash Flow

In the last 12 months, operating cash flow was -$11.33 million and capital expenditures -$18,000, giving a free cash flow of -$11.35 million.

Operating Cash Flow	-11.33M
Capital Expenditures	-18,000
Free Cash Flow	-11.35M
FCF Per Share	-$1.99

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

BCLI does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-69.79%
Shareholder Yield	-69.79%
Earnings Yield	-111.87%
FCF Yield	-89.22%

Analyst Forecast

The average price target for BCLI is $30.00, which is 1,245.29% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$30.00
Price Target Difference	1,245.29%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Splits

The last stock split was on October 1, 2024. It was a reverse split with a ratio of 0.0666667:1.

Last Split Date	Oct 1, 2024
Split Type	Reverse
Split Ratio	0.0666667:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	1